OHMX.bio is off to London for the CB CDx meeting

OHMX.bio is off to London for the CB CDx meeting

This year we’re sponsoring the 13th Clinical Biomarkers & CDx Europe 2023 conference.

Our CSO and Co-founder, Gerben Menschaert, our Director Business Development Companion Diagnostics, Katrien Vanhonacker and our Business developer, Zarel Martinez will be present during this conference to discuss how OHMX.bio can put together an efficient companion diagnostic development program with focus on your success 13th Clinical Biomarkers & CDx Europe 2023. For a listing of all the partners look at https://cdx-europe.com/partnership/partners/.